Teva and DOJ May Reach Settlement in Closely Watched AKS Lawsuit
ArentFox Schiff – Teva Pharmaceuticals filed a request with the First Circuit seeking to hold in abeyance its interlocutory appeal concerning the DOJ's lawsuit alleging violations of the Anti-Kickback Statute (AKS).
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.